SAExploration Holdings, Inc. (NASDAQ:SAEX)’s large shareholder John Pecora acquired 20,000 shares of Common Stock, directly, at $8.4 per share on Monday. This purchase is the fifth consecutive transaction of the shareholder this month, and Pecora now owns a total of 1.82 million shares of the $122 million market cap business. His last acquisition was executed merely two weeks ago, when the shareholder bought 24,231 shares of Common Stock at a price of $7.99 per share. Furthermore, several hedge funds remain confident in their shareholder position at the firm, the fund founded by Noam Gottesman, Glg Partners, holding the largest amount of company…
Author: Melanie Marilin
Evertec Inc. (NYSE:EVTC)’s President and Chief Executive Officer, Peter Harrington, sold a bulk of 50,000 shares of the company’s Common Stock, directly, at a price of $25.04 per share. Concluding the sale, the CEO now holds a total of 230,988 shares of the $1.94 billion market cap processing firm. Although this is the first insider sell of the month, in May several insiders concluded sales transactions. Evertec’s Executive Vice President, Miguel Vizcarrondo sold 35,000 shares for $23.04 per share, while Executive Vice President Carlos J. Ramirez unloaded 40,000 shares for $22.94 per share. The Chief Financial Officer and Executive VP,…
On Monday, Forest City Enterprises, Inc. (NYSE:FCE.A)’s Executive Vice President, James Ratner, sold 191,838 company shares, indirectly. The stock was unloaded in two sales, both on the same day, and for the same price: $19.75 per share. The first transaction was of 91,838 shares, sold indirectly via the Daniel G. Ratner 1993 Trust, of which the Exec. VP is an advisor. The second sale unloaded the remaining 100,000 shares, also indirectly, via a trust fund for his children and grandchildren. This is the third stock sale executed by James Ratner in June, as he unloaded 82,000 shares of Common Stock…
The Director of Acceleron Pharma Inc. (NASDAQ:XLRN), Jean George, completed a three day stock sale transaction yesterday, in which he unloaded a total of 25,477 shares of Common Stock. The sale was initiated this past Friday, when George sold the minor amount of 1,457 shares, indirectly, at a price of $35.02 per share. On Monday the transaction was continued by unloading 13,618 shares, indirectly, at $35.27 per share, to be completed yesterday with the sale of another 10,402 shares, for $35.03 per share. After the sale, the Director of the biopharmaceutical firm holds a total of 1.913,554 shares. While stock…
It would appear that Hercules Offshore, Inc. (NASDAQ:HERO)’s insiders are gaining certainty on taking advantage of the company’s very recent stock price drop, as Director Thomas Bates purchased 20,000 shares of Common Stock, directly, today. The stock was sold at a price of $3.93 per share, which is even lower than the $4.01 per share that Chief Executive Officer and President of Hercules, John Rynd, paid in his stock acquisition reported yesterday. The CEO took advantage of his firm’s low stock price and acquired 36,000 shares of Common Stock. This acquisition trend is bound to continue, as Goldman Sachs’ downgraded…
Yesterday several analysts, such as Goldman Sachs, downgraded Hercules Offshore, Inc. (NASDAQ:HERO) from a neutral position to sell, causing the stock’s price to slip by 3% today. So, taking advantage of the lower price, the company’s Chief Executive Officer and President, John Rynd, purchased 36,000 shares of Common Stock, directly, paying $4.01 per share. Following Rynd’s first stock acquisition this year, the CEO now holds little over 1 million Hercules shares, surpassed only by company Director, Steven Webster. Webster, contrary to the CEO, has been steadily purchasing large bulks of stock over the past quarters, with his latest acquisition dating…
Yesterday, Solazyme Inc. (NASDAQ:SZYM)’s Chief Executive Officer, Jonathan Wolfson, sold 35,000 shares of Common Stock, indirectly, via the Jonathan S. Wolfson Revocable Trust. The shares were sold at a price of $11.78 per share and following the sale, Wolfson remains the majority shareholder with over 2.5 million shares to his name. This sale was the largest one executed in June on behalf of a company insider. Last week, General Counsel Paul Quinlan unloaded 6,000 shares of the $920 million market cap oil producer, for $11.99 per share. Other insider sales this month include Chief Technology Officer, Peter Lacari, who sold…
The Senior Vice President and General Counsel at Kemper Corporation (NYSE:KMPR), Scott Renwick, sold off nearly 10,000 of his company shares in a two-day transaction, completed yesterday. Renwick initiated the sale of his stock on Friday, by unloading 6,000 shares of Common Stock, directly, at a price of $37.01 per share. The second batch of stock was sold yesterday, and included 3,864 shares of Common Stock at the aforementioned price. However, this isn’t the first sale executed by Kemper’s Vice President, as he has been selling off his company shares in small amounts, ranging between 1,000 and 2,000 shares, throughout…
Ruby Tuesday, Inc. (NYSE:RT)’s Concept President and Chief Operating Officer, Todd Burrowes, sold 12,200 of his company shares, directly, yesterday. The stock was sold at a price of $7.34 per share and after the transaction Burrowes still holds 173,916 Ruby Tuesday shares to his name. The COO’s sale is the first to be executed this year, as 2014 showed large stock purchases on behalf of company Director Donald Hess and Chief Executive Officer James Buettgen, both of whom acquired 50,000 shares of the restaurant operator in April and January of 2014. And although Ruby Tuesday has been in the headlines…
Today, three insiders at Quinpario Acquisition Corp (NASDAQ:QPAC) acquired the company’s stock. The Vice President of Operations, Craig Ivey, purchased the smallest sum of the three insiders, buying 15,000 shares of Common Stock at a price of $10.27 per share. This was Ivey’s second stock purchase over the last month, as three weeks ago he reported an acquisition of 10,000 company shares for $10.00 per share. The VP of Operations now holds a total of 36,670 holdings. John Srivisal, Vice President and CFO of the $252 million market cap firm, made his debut purchase with 38,900 shares, bought at the…
After Merrimack Pharmaceuticals Inc. (NASDAQ:MACK)’s stock plummeted by over 10% yesterday, some insiders were clever and took advantage of the price changes regarding the company’s stock, allowing them to purchase large amounts of stock. The talk is of company directors Gary Crocker and Michael Porter. With Merrimack’s stock at a low price of $6.84 per share, Crocker acquired 36,000 shares, indirectly, through his spouse. In spite of the large bulk of stock, this isn’t Crocker’s first purchase this year, as he reported several smaller stock acquisitions in May of this year. Michael Porter bought 32,390 shares of the biopharmaceutical firm,…
On Friday, UDR, Inc. (NYSE:UDR)’s Chief Executive Officer and Director, Thomas Toomey, sold 15,000 shares of Common Stock, directly, at a price of $28.1 per share. The insider sell was the second transaction executed by the CEO this month, as he sold another 15,000 shares of the real estate investment trust on June 5th, at a slightly lower price of $27.9 per share. Following the sale, Toomey remains a majority shareholder at UDR, with almost 1.16 million shares to his name. Prior to the CEO’s sale, several other insiders sold their company stock in May, such as Senior Executive VP,…